Related Experiment Video
Updated: Jul 5, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder
Maria Isabel Saraiva Dinelli1, Maria Isabel de Moraes-Pinto
1Department of Pediatrics, Division of Pediatric Infectious Diseases, Federal University of São Paulo, São Paulo, SP, Brazil. beldin@terra.com.br
Abstract:
Decreased responses to hepatitis B vaccine have been associated with some host conditions including obesity. Susceptible non-responders to a primary three-dose vaccine series should be revaccinated. Those who maintain a non-responder condition after revaccination with three vaccine doses are unlikely to develop protection using more doses. This is a description of an obese woman who received six doses of hepatitis B vaccine and persisted as a non-responder. She was submitted to a vertical banded gastroplasty Roux-en-Y gastric bypass Capellas's technique. After weight reduction, she received three additional doses of vaccine and seroconverted. Further studies should help clarify the need to evaluate antibody levels and eventually revaccinate the increasing population of individuals who undergo weight reduction.
Related Concept Videos
Drug Dosing: Obese Patients
Hepatitis
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Viral Hepatitis I: Introduction
Obesity
